Maryam Shariatzadeh

Maryam is a PhD-educated, life science professional, with over 15 years of experience in translational research and commercial projects for advanced therapies including T-cell processing, Tissue Engineering, Stem Cell Research and product development. After a PharmD (Tehran University of Medical Science) and an MSc in Biotechnology (University of Manchester), Maryam completed her PhD in Tissue Engineering and Biopharmaceutical Science (University of Sheffield). Since joining Rinri Therapeutics in 2019 as a Senior Industrial Scientist, Maryam has led projects exploring the selection and optimization of alternative iPSC parental cell lines to derive future improvements of cell therapy products and has been working closely with partners as a part of the regulatory team in preparation of IMPD and clinical trials.